GPT and metabolic dysfunction-associated steatotic liver disease: AgNPs increased the liver enzymes including AST and ALT in the liver, and enhanced the levels of plasma and hepatic TG and CHOL along with hepatic lipid droplets in HFD-fed mice, indicating potential toxic effects of AgNPs on the liver in NAFLD mice.